TIMP1 and COVID-19: Based on the expression of TIMP1, further analysis by GSEA revealed that the pentose and glucuronate interconversions pathways were significantly enriched in the TIMP1 low expression group, indicating that the metabolic pathways in the brain of COVID-19 patients were disrupted (Figure 5F).